Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A short history of vaccination
Susan L. Plotkin, Stanley A. Plotkin
Vaccines (2013), pp. 1-13
Open Access | Times Cited: 231

Showing 1-25 of 231 citing articles:

Vaccination greatly reduces disease, disability, death and inequity worldwide
André Fe, Robert Booy, H.L. Bock, et al.
Bulletin of the World Health Organization (2008) Vol. 86, Iss. 2, pp. 140-146
Open Access | Times Cited: 1142
Global Burden of Disease
Colin Mathers
Elsevier eBooks (2008), pp. 59-72
Closed Access | Times Cited: 1110
From Vaccines to Memory and Back
Federica Sallusto, Antonio Lanzavecchia, Koichi Araki, et al.
Immunity (2010) Vol. 33, Iss. 4, pp. 451-463
Open Access | Times Cited: 596
Nanotechnology in vaccine delivery
Laura J. Peek, C. Russell Middaugh, Cory Berkland
Advanced Drug Delivery Reviews (2008) Vol. 60, Iss. 8, pp. 915-928
Open Access | Times Cited: 544
History of vaccination
Stanley A. Plotkin
Proceedings of the National Academy of Sciences (2014) Vol. 111, Iss. 34, pp. 12283-12287
Open Access | Times Cited: 537
Design and Analysis of Vaccine Studies
M. Elizabeth Halloran, Ira M. Longini, Cláudio J. Struchiner
Statistics in the health sciences (2009)
Closed Access | Times Cited: 331
Exposure to Perfluorinated Alkyl Substances and Health Outcomes in Children: A Systematic Review of the Epidemiologic Literature
Kristen M. Rappazzo, Evan Coffman, Erin P. Hines
International Journal of Environmental Research and Public Health (2017) Vol. 14, Iss. 7, pp. 691-691
Open Access | Times Cited: 319
Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines
Perry Barrett, Wolfgang Mundt, Otfried Kistner, et al.
Expert Review of Vaccines (2009) Vol. 8, Iss. 5, pp. 607-618
Closed Access | Times Cited: 267
Contributions of humoral and cellular immunity to vaccine-induced protection in humans
Ian J. Amanna, Mark K. Slifka
Virology (2011) Vol. 411, Iss. 2, pp. 206-215
Open Access | Times Cited: 241
EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD)
Qunying Mao, Yiping Wang, Lianlian Bian, et al.
Expert Review of Vaccines (2016) Vol. 15, Iss. 5, pp. 599-606
Closed Access | Times Cited: 192
Old and new adjuvants
Amy S. McKee, Philippa Marrack
Current Opinion in Immunology (2017) Vol. 47, pp. 44-51
Open Access | Times Cited: 179
Nanoparticles and Vaccine Development
Mehdi Kheirollahpour, Mohsen Mehrabi, Naser Mohammadpour Dounighi, et al.
Pharmaceutical Nanotechnology (2019) Vol. 8, Iss. 1, pp. 6-21
Closed Access | Times Cited: 150
Vaccines: the Fourth Century
Stanley A. Plotkin
Clinical and Vaccine Immunology (2009) Vol. 16, Iss. 12, pp. 1709-1719
Open Access | Times Cited: 241
Vaccine Epidemiology: Efficacy, Effectiveness, and the Translational Research Roadmap
Geoffrey A. Weinberg, Peter G. Szilagyi
The Journal of Infectious Diseases (2010) Vol. 201, Iss. 11, pp. 1607-1610
Closed Access | Times Cited: 224
Principles of vaccine design—Lessons from nature
Fred Zepp
Vaccine (2010) Vol. 28, pp. C14-C24
Closed Access | Times Cited: 181
Serologic Vaccination Response after Solid Organ Transplantation: A Systematic Review
Isabella Eckerle, Kerstin Daniela Rosenberger, Marcel Zwahlen, et al.
PLoS ONE (2013) Vol. 8, Iss. 2, pp. e56974-e56974
Open Access | Times Cited: 173
Why the evolution of vaccine resistance is less of a concern than the evolution of drug resistance
David Kennedy, Andrew F. Read
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 51, pp. 12878-12886
Open Access | Times Cited: 125
Vaccinomics, adversomics, and the immune response network theory: Individualized vaccinology in the 21st century
Gregory A. Poland, Richard B. Kennedy, Brett A. McKinney, et al.
Seminars in Immunology (2013) Vol. 25, Iss. 2, pp. 89-103
Open Access | Times Cited: 116
Development of a new hydrogen peroxide–based vaccine platform
Ian J. Amanna, Hans Peter Raué, Mark K. Slifka
Nature Medicine (2012) Vol. 18, Iss. 6, pp. 974-979
Open Access | Times Cited: 114
The Impact of Bioinformatics on Vaccine Design and Development
Ribas‐Aparicio Rosa María, Castelán‐Vega Juan Arturo, Jiménez‐ Alberto Alicia, et al.
Vaccines (2017)
Open Access | Times Cited: 113
Update on Chlamydia trachomatis Vaccinology
Luis M. de la Maza, Guangming Zhong, Robert C. Brunham
Clinical and Vaccine Immunology (2017) Vol. 24, Iss. 4
Open Access | Times Cited: 108
Parental reminder, recall and educational interventions to improve early childhood immunisation uptake: A systematic review and meta-analysis
Hannah Harvey, Nadja Reissland, James Mason
Vaccine (2015) Vol. 33, Iss. 25, pp. 2862-2880
Open Access | Times Cited: 107
Vaccines Against Antimicrobial Resistance
Roberto Rosini, Sonia Nicchi, Mariagrazia Pizza, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 105
Assessment of causality of individual adverse events following immunization (AEFI): A WHO tool for global use
Alberto Eugenio Tozzi, Edwin J. Asturias, Madhava Ram Balakrishnan, et al.
Vaccine (2013) Vol. 31, Iss. 44, pp. 5041-5046
Closed Access | Times Cited: 104
Lower vaccine uptake amongst older individuals living alone: A systematic review and meta-analysis of social determinants of vaccine uptake
Anu Jain, Albert Jan van Hoek, Delia Boccia, et al.
Vaccine (2017) Vol. 35, Iss. 18, pp. 2315-2328
Open Access | Times Cited: 102
Page 1 - Next Page

Scroll to top